Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BGE-102 in Center-Involved Diabetic Macular Edema
NCT07812090Phase 2Recruiting
- Sponsor
- BioAge Labs
- Start
- Aug 2026
- Primary completion
- Nov 2027
- Countries
- 1
01
Overview
A Phase 2 trial of BGE-102 in diabetic macular edema (DME), sponsored by BioAge Labs. Started Aug 2026; status: recruiting.
02
Drugs
BGE-102
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT07812090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07812090.